Company profile
Orano Med
- Industry
- Biotechnology Research
- Employees
- 233
- Headquarters
- Villejuif, Île-de-France
- LinkedIn followers
- 17,435
- Office locations
- 7
Orano Med company summary
Orano Med is a company in the Biotechnology Research industry, headquartered in Villejuif, Île-de-France. On LinkedIn the company has around 233 employees and 17,435 followers. The company lists 7 office locations. Its listed specialties include Nuclear Medicine & Nuclear Industry, Biotechnology, Pharmaceutical, Clinical Trial.
What technology does Orano Med use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Orano Med
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.
Specialties
Where is Orano Med located?
Orano Med lists 7 office locations.
Compare companies similar to Orano Med
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Orano Med oranomed.com | Biotechnology Research | 233 | - | Villejuif, Île-de-France |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Orano Med
What does Orano Med do?
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.
How many employees does Orano Med have?
Orano Med has around 233 employees on LinkedIn.
Where is Orano Med headquartered?
Orano Med is headquartered in Villejuif, Île-de-France.
Where does Orano Med have offices?
Orano Med lists 7 office locations, including Villejuif, Île-de-France, FR; Bessines-sur-Gartempe, 87250, FR; Brownsburg, Indiana, US; Onnaing, 59264, FR; Plano, TX, US.
Build a lead list from companies like Orano Med
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.